CHART REVIEW OF PATIENTS WITH SECONDARY HYPERPARATHYROIDISM AND CALCIMIMETICS IN SPAIN, USING ELECTRONIC HEALTH RECORDS AND BIG DATA TECHNOLOGY.

AN INCREASE OF FREE FATTY ACIDS ON PATIENTS STARTING PERITONEAL DIALYSIS SUGGESTS AN INCREASED CARDIOVASCULAR RISK BEYOND CLASSICAL DYSLIPIDEMIA BIOMARKERS

Lopez Romero, Luis Carlos; (...); Julia Hernández Lluesa

Meeting Abstract. 2022

ASSOCIATIONS OF DISORDERS IN BONE MINERAL PARAMETERS WITH MORTALITY IN STAGE 4 AND 5 CKD: INSIGHTS FROM THE PECERA STUDY

Molina, Pablo; (...); Gorriz, JL

Meeting Abstract. 2020

Clinical Characteristics and Management of Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: A Feasibility Analysis of Electronic Health Records Using Natural Language Processing.

Ortiz A; (...); Rodriguez M

Article. 10.1159/000528784. 2023

• 
• 
• 3

  

Characteristics and technical survival of home hemodialysis in the Valencian Community (1976-2020).

Pérez Alba A; (...); Sánchez Pérez P

Article. 10.1016/j.nefroe.2021.08.010. 2023

Characteristics and technical survival of home hemodialysis in the Valencian Community (1976-2020).

Pérez Alba A; (...); Sánchez Pérez P

Article. 10.1016/j.nefro.2021.08.003. 2021

Disorders in bone-mineral parameters and the risk of death in persons with chronic kidney disease stages 4 and 5: the PECERA study.

Molina P; (...); Górriz JL

Article. 10.1007/s40620-020-00916-9. 2021

• 
• 15

  

Extracellular Kir2.1(C122Y) Mutant Upsets Kir2.1-PIP(2) Bonds and Is Arrhythmogenic in Andersen-Tawil Syndrome.

Cruz FM; (...); Jalife J

Article. 10.1161/CIRCRESAHA.123.323895. 2024

• 
• 
• 3

  

Improvements in Inflammation and Calcium Balance of Citrate versus Acetate as Dialysate Buffer in Maintenance Hemodialysis: A Unicentric, Cross-Over, Prospective Study.

Broseta JJ; (...); Hernández-Jaras J

Article. 10.1159/000513419. 2021

• 9

  

Metabolic Pathways Affected in Patients Undergoing Hemodialysis and Their Relationship with Inflammation.

Peris-Fernández M; (...); Hernández-Jaras J

Article. 10.3390/ijms25179364. 2024

Peripheral access ultrafiltration as a treatment for cardiorenal syndrome with inadequate diuretic response. Initial experience

Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar

Letter. 10.1016/j.recesp.2022.04.017. 2023

• 3

  

Practical Requirements for the Development of an Advanced Cardiorenal Unit

Almenar-Bonet, Luis; (...); Sanchez-Perez, Pilar

Review. 10.1159/000536104. 2024

• 
• 
• 2

  

Results of a healthcare organization model for COVID-19 on hemodialysis in a tertiary hospital and its subsidized centers

Sanchez-Perez, P; (...); Lacueva-Moya, J

Article. 10.1016/j.nefro.2020.05.006. 2020

• 
• 
• 8

  

Therapeutic approach in heart failure with poor diuretic response: peripheral ultrafiltration vs. conventional treatment.

López-Vilella R; (...); Almenar Bonet L

Article. 10.1002/ehf2.14386. 2023

• 
• 
• 12

  

Treatment of Chronic Heart Failure in Advanced Chronic Kidney Disease: The HAKA Multicenter Retrospective Real-World Study.

Quiroga B; (...); Díez J

Article. 10.1159/000538030. 2024

• 
• 
• 4

  

Ultrafiltracion de acceso periferico como tratamiento del sindrome cardiorrenal con insuficiente respuesta diuretica. Experiencia inicial.

Lopez-Vilella, Raquel; (...); Bonet, Luis Almenar

Art Exhibit Review. 10.1016/j.rec.2022.04.013. 2022

• 
• 7

  

Unraveling enteric peritonitis risk factors: the role of nutrition

Mompo-Ramos, Mar; (...); Hernandez Jaras, Julio

Meeting Abstract. 10.1093/ndt/gfae069.924. 2024

Uremic Toxins and Inflammation: Metabolic Pathways Affected in Non-Dialysis-Dependent Stage 5 Chronic Kidney Disease

Peris-Fernandez, Maria; (...); Hernandez-Jaras, Julio

Article. 10.3390/biomedicines12030607. 2024

• 
• 
• 9

  

Uremic toxins and inflammation: Metabolic pathways affected in stage 5 kidney disease

Peris-Fernandez, Maria; (...); Hernandez Jaras, Julio

Meeting Abstract. 10.1093/ndt/gfae069.483. 2024